In recognition of 10 years of publication Future Cardiology has launched a special issue focused on recent advances and emerging challenges in specific areas of cardiology. The journal features articles written by members of its editorial board focused on developing treatments and issues in cardiac care for women, blood pressure targets, and the evolution of genetics and drug response. Future Cardiology is published bimonthly by Future Science Group.
"We launched this journal in recognition of both the rapid rate of advancement in our field and the growing patient population, and we are pleased to offer a review of three critical areas of development in cardiac research and treatment," said Ellen Clarke, Commissioning Editor. "We are always delighted to include the work of the researchers that make up our editorial board; their hard work over the years has been a great assistance in maintaining the journal's high standards at a time when advancement in our field is exceptional."
The three featured articles include "Blood Pressure Target Goals From Guidelines of 2002 to 2014," by Wilbert S. Aronow, MD; "Evolving Cardiovascular Care for Women: A Decade of Progress," by Nanette K. Wenger, MD; and "Pharmacogenomics in Cardiology - Genetics and Drug Response: 10 Years of Progress," by Larisa H. Cavallari, MD.
Dr. Aronow reviews hypertension guidelines from 2002 to 2014, specifically focusing on differing recommendations on whether or not to reduce systolic blood pressure for older patients. "I agree with the 2014 Joint National Committee minority report recommending that these older persons should have their systolic blood pressure reduced to less than 140 mm Hg to reduce cardiovascular events," said Dr. Aronow. "The recently published 2015 American Heart Association/American College of Cardiology/American Society of Hypertension scientific statement on treatment of hypertension in patients with coronary artery disease also recommends reducing the systolic blood pressure to less than 140 mm Hg in these older persons."